Skip to main content
Past Event

New Policy Directions for Biomedical Innovation

Past Event

New Policy Directions for Biomedical Innovation

On November 19, the Engelberg Center for Health Care Reform at Brookings hosted an event examining the outlook and opportunities for biomedical innovation in a challenging fiscal environment. Leaders in the field offered their thoughts on future directions of and policy priorities for the innovation enterprise. Following a brief keynote, a panel of senior thought leaders provided further discussion on actionable next steps to improve biomedical innovation.

Download the executive summary » (PDF)
Download the panelist biographies » (PDF)



Priorities for Biomedical Innovation in a Challenging Fiscal Environment

Finding the Path Forward for Biomedical Innovation


Christopher Austin

Director, National Center for Advancing Translational Sciences - National Institutes of Health


Deborah Brooks

Co-Founder and Executive Vice Chairman - The Michael J. Fox Foundation


Robert Conley

Regulatory Leader and Distinguished Lilly Scholar - Eli Lilly and Company


John Mendelsohn

Professor, Department of Experimental Therapeutics, Division of Cancer Medicine and Director, Khalifa Institute for Personalized Cancer Therapy - The University of Texas MD Anderson Cancer Center


Earl Steinberg

Executive Vice President of Innovation & Dissemination - Geisinger Health Solutions

Closing Remarks

More Information

To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.

Get a weekly events calendar from Brookings